Summary of top read business stories July 26 to 31

However, Malaysia University of Science and Technology or MUST professor Dr Geoffrey Williams believes Malaysia will see a long-haul recovery.

Top read stories include AstraZenecca, Pos Malaysia, AIA Malaysia and TNG Digital, Silterra, National Recovery Plan, food delivery platforms

AstraZeneca's Covid-19 shot did not increase the instances of rare blood clots with low platelets in people after the second dose, a study showed on Wednesday, potentially easing some worries over the vaccine's side-effects.